JP2023513720A5 - - Google Patents
Info
- Publication number
- JP2023513720A5 JP2023513720A5 JP2022548783A JP2022548783A JP2023513720A5 JP 2023513720 A5 JP2023513720 A5 JP 2023513720A5 JP 2022548783 A JP2022548783 A JP 2022548783A JP 2022548783 A JP2022548783 A JP 2022548783A JP 2023513720 A5 JP2023513720 A5 JP 2023513720A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- protein
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062977036P | 2020-02-14 | 2020-02-14 | |
| US62/977,036 | 2020-02-14 | ||
| US202063046159P | 2020-06-30 | 2020-06-30 | |
| US63/046,159 | 2020-06-30 | ||
| US202063064235P | 2020-08-11 | 2020-08-11 | |
| US63/064,235 | 2020-08-11 | ||
| PCT/US2021/017799 WO2021163438A1 (en) | 2020-02-14 | 2021-02-12 | Polypeptides, compositions, and their use to treat or limit development of an infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023513720A JP2023513720A (ja) | 2023-04-03 |
| JP2023513720A5 true JP2023513720A5 (https=) | 2024-02-19 |
Family
ID=74873805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548783A Pending JP2023513720A (ja) | 2020-02-14 | 2021-02-12 | 感染症の治療又は発症を制限するためのポリペプチド、組成物、及びそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240277831A1 (https=) |
| EP (1) | EP4103230A1 (https=) |
| JP (1) | JP2023513720A (https=) |
| KR (1) | KR20220142472A (https=) |
| CN (1) | CN116096404A (https=) |
| AU (1) | AU2021221139A1 (https=) |
| BR (1) | BR112022016220A2 (https=) |
| CA (1) | CA3167318A1 (https=) |
| CO (1) | CO2022011467A2 (https=) |
| MX (1) | MX2022009860A (https=) |
| PE (1) | PE20230301A1 (https=) |
| PH (1) | PH12022552099A1 (https=) |
| WO (1) | WO2021163438A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12194089B2 (en) | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
| US11241493B2 (en) | 2020-02-04 | 2022-02-08 | Curevac Ag | Coronavirus vaccine |
| JP2023521418A (ja) | 2020-04-10 | 2023-05-24 | インビビド， インコーポレイテッド | コロナウイルスｓタンパク質に特異的な化合物及びその使用 |
| WO2022016122A2 (en) * | 2020-07-17 | 2022-01-20 | Tonix Pharmaceuticals Holding Corp. | Skin-based testing for detection of cell-mediated immune responses to sars-cov-2 |
| US11918643B2 (en) | 2020-12-22 | 2024-03-05 | CureVac SE | RNA vaccine against SARS-CoV-2 variants |
| US20220324918A1 (en) * | 2021-03-30 | 2022-10-13 | Regents Of The University Of Minnesota | SARS-CoV-2 SPIKE ECTODOMAIN POLYPEPTIDES AND COMPOSITIONS AND METHODS THEREOF |
| WO2023034991A1 (en) * | 2021-09-02 | 2023-03-09 | Kansas State University Research Foundation | Mrna vaccine formulations and methods of using the same |
| US20240385189A1 (en) * | 2021-09-10 | 2024-11-21 | Jacobs Technion-Cornell Institute | Compositions and methods for determining humoral immune responses against seasonal coronaviruses and predicting efficiency of sars-cov-2 spike targeting, covid-19 disease severity, and providing interventions |
| KR102527221B1 (ko) * | 2021-10-15 | 2023-05-02 | 에스케이바이오사이언스 주식회사 | 단백질의 정제방법 |
| KR102621026B1 (ko) * | 2021-10-15 | 2024-01-09 | 에스케이바이오사이언스(주) | 단백질의 정제방법 |
| KR102524839B1 (ko) * | 2021-11-04 | 2023-04-25 | 에스케이바이오사이언스(주) | 사스-코로나바이러스-2 감염증 예방 또는 치료용 백신 조성물 |
| US20250000968A1 (en) * | 2021-11-12 | 2025-01-02 | The United States of America, as represented by the Secretary,Department of Health and Human Service | Sars-cov-2 spike fused to a hepatitis b surface antigen |
| WO2023122257A2 (en) * | 2021-12-22 | 2023-06-29 | La Jolla Institute For Immunology | Coronavirus spike glycoprotein with improved expression and stability |
| CN114656571B (zh) * | 2022-02-18 | 2024-07-16 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种四价SARS-CoV-2嵌合纳米颗粒疫苗及其制备方法与应用 |
| US20240207389A1 (en) * | 2022-04-27 | 2024-06-27 | Northwestern University | Methods for improving covid vaccine immunogenicity |
| WO2024014943A1 (ko) * | 2022-07-12 | 2024-01-18 | 에스케이바이오사이언스 주식회사 | Sars-cov-2 백신 부스터 조성물 |
| WO2024076982A2 (en) * | 2022-10-05 | 2024-04-11 | University Of Washington | Pan-sarbecovirus nanoparticle vaccines |
| EP4608442A1 (en) | 2022-10-28 | 2025-09-03 | GlaxoSmithKline Biologicals S.A. | Nucleic acid based vaccine |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA017887B1 (ru) * | 2007-08-02 | 2013-03-29 | Байондвакс Фармасьютикалз Лтд. | Полимерные мультиэпитопные вакцины против гриппа |
| US10248758B2 (en) * | 2013-02-07 | 2019-04-02 | University Of Washington Through Its Center For Commercialization | Self-assembling protein nanostructures |
| CN105934441A (zh) * | 2013-11-26 | 2016-09-07 | 贝勒医学院 | 新型sars免疫原性组合物 |
| US9630994B2 (en) * | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| US10676511B2 (en) * | 2015-09-17 | 2020-06-09 | Ramot At Tel-Aviv University Ltd. | Coronaviruses epitope-based vaccines |
| WO2018175560A1 (en) * | 2017-03-22 | 2018-09-27 | The Scripps Research Institute | Nanoparticle immunogens to elicit responses against the influenza receptor binding site on the hemagglutinin head domain |
| HUE073526T2 (hu) * | 2017-04-04 | 2026-01-28 | Univ Washington | Önmagát összeállító fehérje nanostruktúrák, amelyek paramyxovírus és/vagy pneumovírus F fehérjéket jelenítenek meg és azok használata |
| WO2019169120A1 (en) * | 2018-02-28 | 2019-09-06 | University Of Washington | Self-asssembling nanostructure vaccines |
-
2021
- 2021-02-12 WO PCT/US2021/017799 patent/WO2021163438A1/en not_active Ceased
- 2021-02-12 AU AU2021221139A patent/AU2021221139A1/en active Pending
- 2021-02-12 PE PE2022001743A patent/PE20230301A1/es unknown
- 2021-02-12 CA CA3167318A patent/CA3167318A1/en active Pending
- 2021-02-12 BR BR112022016220A patent/BR112022016220A2/pt unknown
- 2021-02-12 MX MX2022009860A patent/MX2022009860A/es unknown
- 2021-02-12 KR KR1020227031351A patent/KR20220142472A/ko active Pending
- 2021-02-12 CN CN202180028727.9A patent/CN116096404A/zh active Pending
- 2021-02-12 US US17/760,174 patent/US20240277831A1/en active Pending
- 2021-02-12 EP EP21711980.9A patent/EP4103230A1/en active Pending
- 2021-02-12 PH PH1/2022/552099A patent/PH12022552099A1/en unknown
- 2021-02-12 JP JP2022548783A patent/JP2023513720A/ja active Pending
-
2022
- 2022-08-16 CO CONC2022/0011467A patent/CO2022011467A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023513720A5 (https=) | ||
| JP7523897B2 (ja) | 呼吸器合胞体ウイルス（ｒｓｖ）ワクチン | |
| KR102351555B1 (ko) | Hpv 및 관련 질환용 면역 증강 치료 백신 | |
| US10059747B2 (en) | Crimean-congo haemorrhagic fever virus antigenic composition | |
| JP6595132B2 (ja) | Ｈｉｖワクチン製剤 | |
| WO2020063370A2 (zh) | 免疫组合物及其制备方法与应用 | |
| WO2019092002A1 (en) | Pharmaceutical compositions for treatment or prevention of viral infections | |
| JP2016517414A (ja) | インフルエンザ核酸分子及びそれから作製したワクチン | |
| JP2024508683A5 (https=) | ||
| US12390518B2 (en) | Immunogenic composition | |
| JP2018536002A5 (https=) | ||
| WO2023051701A1 (zh) | 抗SARS-CoV-2感染的mRNA、蛋白以及抗SARS-CoV-2感染的疫苗 | |
| US20240207385A1 (en) | Compositions comprising self-assembling vaccines and methods of using the same | |
| Zhao et al. | Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine | |
| JP2010535504A5 (https=) | ||
| EP3713600B1 (en) | Synthetic hemagglutinin as universal vaccine against infection by type b influenza viruses (ibv) | |
| JP5901084B2 (ja) | ペプチドアジュバント | |
| CN113476600B (zh) | Avc-29作为疫苗佐剂的用途以及含有该佐剂的疫苗组合物 | |
| KR20250054292A (ko) | 중증열성혈소판감소증후군 바이러스에 대한 신규 백신 | |
| WO2022127820A1 (zh) | 病原样抗原疫苗及其制备方法 | |
| JP2002510496A (ja) | 細胞傷害性ｔ細胞を誘導するための医薬 | |
| WO2023187366A1 (en) | Immunogenic compositions for the prevention of influenza a | |
| WO2025084106A1 (ja) | 経鼻投与による細胞性免疫の誘導方法 | |
| Dabaghian et al. | Use of N-trimethyl chitosan for intranasal delivery of DNA encoding M2e-HSP70c in mice | |
| CN117120617A (zh) | 新型核酸分子 |